Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tyroserleutide in Hepatocellular Carcinoma
NCT01489566Phase 3Unknown
- Sponsor
- Shenzhen Kangzhe Pharmaceutical Co., Ltd.
- Start
- Jul 2011
- Primary completion
- Mar 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tyroserleutide in hepatocellular carcinoma (HCC), sponsored by Shenzhen Kangzhe Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
tyroserleutide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01489566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01489566.